Stay updated on Evobrutinib Study in RMS Clinical Trial
Sign up to get notified when there's something new on the Evobrutinib Study in RMS Clinical Trial page.

Latest updates to the Evobrutinib Study in RMS Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedFooter shows a revision update from v3.4.1 to v3.4.2; no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. No study details, eligibility criteria, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedThe page adds a Show glossary option and minor wording changes to QC-related labels (e.g., Last Update Submitted that Met QC Criteria and No FEAR Act Data) and a new revision note (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check67 days agoChange DetectedA new Locations section appears with Massachusetts listed as a site. The page revision updates to v3.3.3 and the existing Massachusetts Locations and HHS Vulnerability Disclosure entries are removed.SummaryDifference0.2%

- Check95 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

Stay in the know with updates to Evobrutinib Study in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evobrutinib Study in RMS Clinical Trial page.